Studies discussed in this review suggest that prodromal signs of neurodegenerative diseases observable in the retina could potentially complement currently used biomarkers, such as plasma/blood biomarkers (e.g., p-tau181 and α-synuclein), for the early detection of neurodegenerative diseases. Here, SNCA is linked to neurodegenerative disease.